Issues in obesity monitoring, screening and subsequent treatment

Melissa Wake1

  • 1Centre for Community Child Health, Royal Children's Hospital and Murdoch Childrens Research Institute, Department of Paediatrics, The University of Melbourne, Parkville, Melbourne, Victoria, Australia. melissa.wake@rch.org.au

Insights

Childhood obesity rates are rising, but screening children's body mass index (BMI) is not proven effective. Prioritizing research into prevention and intervention is recommended over population screening.

Area of Science:

  • Pediatric Health
  • Public Health Policy
  • Epidemiology

Background:

  • Childhood obesity rates continue to escalate globally, despite significant attention.
  • Obesity in children often does not resolve spontaneously, yet few seek treatment.
  • This review examines the evidence supporting and opposing the monitoring and screening of children's body mass index (BMI).

Purpose of the Study:

  • To evaluate the effectiveness and implications of childhood BMI monitoring and screening.
  • To inform policy and research priorities regarding childhood obesity interventions.

Main Methods:

  • Systematic review of recent evidence on childhood BMI screening and monitoring.
  • Analysis of randomized controlled trials (RCTs) on BMI outcomes.
  • Consideration of feasibility, acceptability, cost, and population trends.

Main Results:

  • Population screening of children's BMI is feasible and acceptable but costly, with no demonstrated improvement in BMI outcomes from RCTs.
  • Childhood BMI trends are complex, with higher overweight rates in some birth cohorts not always persisting into adulthood.
  • The long-term effects of increased thinness alongside overweight trends are not fully understood.

Conclusions:

  • Systematic BMI monitoring, potentially using representative samples, is essential but does not require continuous individual tracking.
  • BMI screening is not currently recommended due to a lack of effective management strategies for overweight/mildly obese children.
  • Research efforts should focus on prevention and intervention strategies rather than population-wide screening at this time.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...